XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Net sales $ 1,764 $ 2,749 $ 5,305 $ 7,460
Cost of sales 1,927 2,186 5,385 5,951
Gross (loss) profit (163) 563 (80) 1,509
Operating expenses:        
Product development 366 404 1,222 1,427
Selling, general, and administrative 1,802 1,968 5,893 6,454
Loss on write-off of fixed assets 76 0 76 0
Restructuring expense (recovery) 0 1 0 (21)
Total operating expenses 2,244 2,373 7,191 7,860
Loss from operations (2,407) (1,810) (7,271) (6,351)
Other expenses (income):        
Interest expense 235 177 679 520
Gain on forgiveness of Paycheck Protection Program loan 0 0 0 (801)
Other income 0 (862) (30) (862)
Other expenses 20 15 49 47
Net loss $ (2,662) $ (1,140) $ (7,969) $ (5,255)
Net loss per common share - basic and diluted        
Net loss, basic (USD per share) $ (0.29) $ (0.22) $ (1.05) $ (1.22)
Net loss, diluted (USD per share) $ (0.29) $ (0.22) $ (1.05) $ (1.22)
Weighted average shares of common stock outstanding:        
Basic weighted average common shares outstanding (in shares) 9,190 5,086 7,608 4,309
Diluted weighted average common shares outstanding (in shares) 9,190 5,086 7,608 4,309